An email has been sent to your address with instructions for changing your password.
There is no user registered with this email.
Sign Up
To create a free account, please fill out the form below.
Thank you for signing up!
A confirmation email has been sent to your email address. Please check your email and follow the instructions in the message to complete the registration process. If you do not receive the email, please check your spam folder or contact us for assistance.
Welcome to our platform!
Oops!
Something went wrong while trying to create your new account. Please try again and if the problem persist, Email Us to receive support.
Veracyte to Present at Upcoming Investor Conferences
Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
Rhea-AI Summary
Veracyte (Nasdaq: VCYT) has announced CEO Marc Stapley and CFO Rebecca Chambers will present at the William Blair 42nd Annual Growth Stock Conference on June 8, 2022, at 10:40 a.m. PT, and at the Goldman Sachs 43rd Annual Global Healthcare Conference on June 13, 2022, at 2:40 p.m. PT. Live audio webcasts will be accessible on Veracyte's website, with replays available for 90 days post-event. Veracyte is a global diagnostics firm focused on improving patient care through advanced diagnostic tests that address prevalent cancers and reduce unnecessary procedures.
Positive
None.
Negative
None.
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--
Veracyte, Inc. (Nasdaq: VCYT) announced today that Marc Stapley, chief executive officer, and Rebecca Chambers, chief financial officer, will participate in two upcoming investor conferences. Veracyte will present at the William Blair 42nd Annual Growth Stock Conference on Wednesday, June 8, and will participate in a fireside chat at the Goldman Sachs 43rd Annual Global Healthcare Conference on Monday, June 13.
Event: William Blair 42nd Annual Growth Stock Conference Date: Wednesday, June 8, 2022 Time: 10:40 a.m. PT / 1:40 p.m. ET
Event: Goldman Sachs 43rd Annual Global Healthcare Conference
Date: Monday, June 13, 2022 Time: 2:40 p.m. PT / 5:40 p.m. ET
Live audio webcasts of the company’s presentations will be available by visiting Veracyte’s website at http://investor.veracyte.com/events-presentations. Replays of the webcasts will be available for 90 days following the conclusion of each live presentation broadcast.
About Veracyte
Veracyte (Nasdaq: VCYT) is a global diagnostics company that improves patient care by answering important clinical questions to inform diagnosis and treatment decisions. Our growing menu of advanced diagnostic tests help patients avoid risky, costly procedures and interventions, and reduce time to appropriate treatment. Our tests address eight of the 10 most prevalent cancers by incidence in the United States. In addition to making our tests available in the United States through our central laboratories, our exclusive license to a best-in-class diagnostics instrument positions us to deliver our tests to patients worldwide through laboratories that can perform them locally. Veracyte is based in South San Francisco, California. For more information, please visit www.veracyte.com and follow the company on Twitter (@veracyte).
